BC Extra | Nov 14, 2019
Company News

Via Allergan hair loss deal, Exicure builds balance sheet to advance oncology, neurology pipeline

A collaboration deal giving Allergan options to obtain rights to Exicure's hair loss programs will provide the biotech with non-dilutive cash to further advance a pipeline of spherical nucleic acid (SNA) therapeutics for oncology, neurology...
Items per page:
1 - 1 of 1